SCHEMBL31051506

SCHEMBL31051506

Fc1cc(N2CCOCC2)ccn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.46
▸ LGMN Q99538 1/20 0.45
▸ CDK1 P06493 1/20 0.45
▸ CDK2 P24941 1/20 0.45
▸ PIK3CA P42336 3/20 0.43
▸ PRKDC P78527 3/20 0.42
▸ PIK3CD O00329 2/20 0.42
▸ PIK3CB P42338 2/20 0.42
▸ MAPK10 P53779 2/20 0.42
▸ MAPK13 O15264 1/20 0.42
▸ MAPK8 P45983 1/20 0.42
▸ MAPK12 P53778 1/20 0.42
▸ MAPK11 Q15759 1/20 0.42
▸ MAPK14 Q16539 1/20 0.42
▸ MAPT P10636 4/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ HTT P42858 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21807926 1.00 LMNA (0.46) LMNALGMNCDK1CDK2PIK3CA
SCHEMBL15918731 0.83 CHKA (0.52) LMNAMAPTMEN1ALDH1A1HTT
SCHEMBL29529691 0.81 HRH4 (0.54) LMNAMAPTNPC1RAB9AMEN1
SCHEMBL27936855 0.80 LRRK2 (0.59) LMNALGMNCDK1CDK2PIK3CA
SCHEMBL31051504 0.79 HRH4 (0.59) MAPTNPC1RAB9AMEN1HTT
SCHEMBL21807915 0.79 HRH4 (0.59) MAPTNPC1RAB9AMEN1HTT
SCHEMBL3304237 0.79 LMNA (0.46) LMNALGMNCDK1CDK2PIK3CA
SCHEMBL3724026 0.79 LMNA (0.46) LMNALGMNCDK1CDK2PIK3CA
SCHEMBL30900618 0.79 LMNA (0.46) LMNALGMNCDK1CDK2PIK3CA
SCHEMBL17706687 0.79 LGMN (0.49) LMNALGMNCDK1CDK2PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113166137-B O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranoside enzyme inhibitors 比奥根MA公司 2024-08-16 — — CN disclosed
Send feedback